Bell H, Raknerud N
Medisinsk avdeling, Aker sykehus, Oslo.
Tidsskr Nor Laegeforen. 1991 Jan 30;111(3):322-3.
A 49 year old female was started on disulfiram. Six weeks later she was given naproxen because of epicondylitis. After 5 days' treatment with naproxen she complained of nausea, anorexia and jaundice. At admission, bilirubin was 452 mumol/l, aspartate aminotransferase (ASAT) 1925 U/I, alanine aminotransferase (ALAT) 2815 U/I and prothrombin time measured as Normotest was 27%. The patient developed a fulminant hepatitis and died in hepatic coma almost four weeks after the introduction of naproxen. Postmortem examination disclosed a small liver (1,100 g) and histological examination showed massive necrosis and collapse of the lobules. The naproxen was the most probable cause of death, but it is impossible to exclude disulfiram as causative agent.
一名49岁女性开始服用双硫仑。六周后,她因患有上髁炎而服用了萘普生。在用萘普生治疗5天后,她出现恶心、厌食和黄疸症状。入院时,胆红素为452微摩尔/升,天冬氨酸转氨酶(ASAT)为1925国际单位/升,丙氨酸转氨酶(ALAT)为2815国际单位/升,用正常凝血酶原时间测定法测得的凝血酶原时间为27%。该患者发展为暴发性肝炎,在开始服用萘普生近四周后死于肝昏迷。尸检发现肝脏较小(1100克),组织学检查显示小叶出现大片坏死和塌陷。萘普生很可能是死亡原因,但无法排除双硫仑作为致病因素。